Navigation Links
Markteinführung neuer Assays für Magen-Darm Infektionen in Europa
Date:4/17/2013

, Cryptosporidium spp. (C. hominus und C. parvum) sowie Entamoeba histolytica direkt aus Stuhlproben bei Patienten mit Anzeichen und Symptomen für eine Gastroenteritis und/oder Kolitis entwickelt.

BD plant, das Angebot an molekulare Tests für das BD MAX System durch eigene Entwicklungen und die Zusammenarbeit mit Diagenode weiter auszubauen und über das Jahr  2013 weitere Assays in den Markt einzuführen.

Informationen zu BDBD ist ein führendes, globales Unternehmen der Medizintechnik und entwickelt, produziert und vertreibt medizinische Geräte, Instrumentensysteme und Reagenzien. Das Unternehmen setzt sich für die Verbesserung der Gesundheit der Menschen in aller Welt ein. Insbesondere konzentriert sich BD auf Verbesserungen der Arzneimittelverabreichung, die bessere und schnellere Diagnostik von Infektions- und Krebserkrankungen sowie auf Fortschritte bei der Erforschung, Entdeckung und Herstellung neuer Medikamente und Impfstoffe. Mit seinen Fähigkeiten leistet BD einen entscheidenden Beitrag zur Bekämpfung vieler der dringendsten Gesundheitsprobleme der Welt. BD wurde im Jahr 1897 gegründet, hat seinen Hauptsitz in Franklin Lakes (New Jersey) und beschäftigt etwa 30.000 Mitarbeiter in über 50 Ländern in aller Welt. Das Unternehmen arbeitet mit medizinischen Einrichtungen, biowissenschaftlichen Forschungsinstituten, klinischen Labors, der Pharmaindustrie und der allgemeinen Öffentlichkeit zusammen. Weitere Informationen finden Sie unter www.bd.com.

Informationen zu Diagenode Diagenode (http://www.diagenodediagnostics.com) ist ein führender Entwickler und Vermarkter innovativer Life-Science-Tools und Systeme für Epigenetik und Molekulardiagnostik. Diagenode entwickelt neuartige Produkte für den
'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. invendo medical gibt Markteinführung für computergestütztes Koloskopiesystem zur einmaligen Verwendung nach spezieller 510(k)-Freigabe durch die US-Arzneimittelbehörde FDA bekannt
2. Pinnacle Biologics beantragt Zulassung neuer Indikationen in Deutschland und Frankreich
3. Profil Institute and Mercodia Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials
4. Genalyte Awarded $500,000 SBIR Grant To Develop Multiplexed Assays For Early Detection And Monitoring Of Type 1 Diabetes
5. ChanTest Awarded $1 Million Grant for Predictive Assays using Stem Cell-Derived Human Cardiomyocytes
6. Nuovi dati rivelano il crescente problema dellosteoporosi in Europa
7. Neue klinische Richtlinien für ältere Patienten mit Typ 2 Diabetes, um einen europaweiten Pflegenotstand zu verhindern
8. United BioSource Corp. erweitert mit entscheidender Neubesetzung Potenzial in Europa
9. Neue europaweite Umfrage Ergibt, dass die Behandlung chronischer Schmerzen bei vielen Patienten unzureichend ist
10. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
11. Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... -- Ortho Clinical Diagnostics (OCD) today announced that ... and Communications Officer, effective immediately. As the newest member ... the company,s worldwide corporate brand and communication strategies as ... company by adding sites in countries outside the U.S. ... Dr. Martin Madaus . Since becoming ...
(Date:8/3/2015)... Global physiotherapy equipments ... 24.7 billion by 2022, according to a new ... of neurological and musculoskeletal disorders are expected to ... period. The presence of efficient and effective therapies ... technologies coupled with implementation of favorable government policies ...
(Date:8/3/2015)... ANGELES, Aug. 3, 2015  CytRx Corporation (NASDAQ: ... in oncology, today reported financial results for the three ... overview of recent accomplishments and upcoming milestones for its ... 2015 has been very productive for CytRx. Enrollment in ... aldoxorubicin in soft tissue sarcoma (STS) continues on track ...
Breaking Medicine Technology:Ortho Clinical Diagnostics Appoints Kristie Bouryal Chief Corporate Brand and Communications Officer 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 3Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 4Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 5CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14
... Dec. 4 Long-term data published in,EuroIntervention showed ... (MVA),after repair with the MitraClip(R) system to correct ... mitral stenosis. Additionally,with two years of follow-up, none ... surgery for mitral stenosis. At 12 months no,important ...
... newly diagnosed patients with a life-threatening type of leukemia to be ... , - Exjade results at ASH to show benefits ... damage key organs , , - ... to report on optimal post-surgery treatment strategy, Femara vs. tamoxifen , ...
Cached Medicine Technology:Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 2Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 3Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 5More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 6More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 7More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 8More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 9More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 10More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 11More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 12More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 13More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 14More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 15More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 16More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 17More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 18More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 19More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 20More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 21More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 22
(Date:8/3/2015)... Irvine, CA (PRWEB) , ... August 03, 2015 ... ... for Hispanic Health notes that while an overwhelming number of Hispanics believe ... health. , The overwhelming 70 percent of participants queried said making diet changes ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... of its industry-defining contract lifecycle management solution, as well as announced the date ... increase the speed and ease of contract management tasks as well as enhancements ...
(Date:8/3/2015)... OR (PRWEB) , ... August 03, 2015 , ... ... California’s Modoc National Forest, to Ahjumawi Lava Springs, California’s northernmost and among its ... California’s largest untapped ground water aquifers, whose main outflow is at Ahjumawi Lava ...
(Date:8/3/2015)... ... August 03, 2015 , ... Illinois Health & Science ... 31. , The acquisition includes all of IBAM NA’s cyclotron sites and research ... both, a robust regionally located business, as well as a large manufacturing hub in ...
(Date:8/3/2015)... ... , ... Foot and Ankle Specialists of the Mid-Atlantic (FASMA) is ... practice in the Mid-Atlantic region – and the second largest in the United States ... , Dr. Hetal Kathrotiya-Mago is a Maryland native. She grew up in Laurel, Maryland. ...
Breaking Medicine News(10 mins):Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:Novatus Unveils Milestone Software Release 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4
... less likely, women more, to develop the disorder, study finds, ... a neurological disorder characterized by a strong urge to move ... than others, a new U.S. study has found. , Researchers ... About 12 percent of those who were black, compared with ...
... National Laboratory are collaborating on a study to determine ... the space shuttle can be used to predict tissue ... therapy. The study is examining the utility of ... from the study are being displayed during the American ...
... currently under development by the University of Pittsburgh School ... after radiation exposure, according to a study by Pitt ... p.m. today during the American Society for Radiation Oncology ... is a free-radical scavenger targeted to the mitochondria, the ...
... in packaging, paper and exposures were evident in most ... -- Chemicals used in food packaging, paper and textile ... researchers have found. , Previous studies have found that ... most people. In this new study, a team at ...
... Skin Cell is the Star Avatar at KidsSkinHealth.org , SCHAUMBURG, ... by dermatologists lets kids learn how to practice ... , greasy hair, a poison ivy rash ... Cell,s Life," is just one of the many features on the American ...
... 2 Blue Cross Blue Shield of Michigan and ... innovative oncology treatment initiative aimed at enhancing the quality ... , OPR, a statewide physician organization comprised ... working with oncology leaders from across Michigan, as well ...
Cached Medicine News:Health News:Restless Legs May Vary by Race and Gender 2Health News:Adapting space-industry technology to treat breast cancer 2Health News:Adapting space-industry technology to treat breast cancer 3Health News:Household Chemicals May Affect Cholesterol Levels 2Health News:Dermatologists Launch New Web Site and Game to Teach Kids about Healthy Skin, Hair and Nail Habits 2Health News:Dermatologists Launch New Web Site and Game to Teach Kids about Healthy Skin, Hair and Nail Habits 3Health News:Blue Cross Blue Shield of Michigan and Michigan Oncologists Launch Statewide Initiative to Create Cancer Guidelines 2Health News:Blue Cross Blue Shield of Michigan and Michigan Oncologists Launch Statewide Initiative to Create Cancer Guidelines 3
For surgical treatment, repair and irrigation of the nasolacrimal system. Stainless steel probes, 20G x 1 3/4in (.90 x 45cm) Silicone rod, length 13 3/4in (40cm), Diameter.032in (.80mm)...
For surgical treatment, repair and irrigation of the nasolacrimal system. Stainless steel probes, 23G x4 1/2in (.60mm x 11cm) Silicone tubing, length 14in (35cm), ID: .012in (.30mm) OD: .025in (.60mm...
IOL choppers for positioning intraocular lenses. Blunt tip avoids damage to intraocular lenses. For .20mm diameter holes and larger....
...
Medicine Products: